Article
The HTR3A polymorphism c. -42C>T is associated with amygdala responsiveness in patients with irritable bowel syndrome.
Gastroenterology - 1 Jun 2011
Kilpatrick Lisa A, Labus Jennifer S, Coveleskie Kristen, Hammer Christian, Rappold Gudrun, Tillisch Kirsten, Bueller Joshua A, Suyenobu Brandall, Jarcho Johana M, McRoberts Jim A, Niesler Beate, Mayer Emeran A
Abstract excerpt
BACKGROUND & AIMS: 5-Hydroxytryptamine (5-HT)3 receptor (5-HT3R) antagonists are effective in treating patients with irritable bowel syndrome (IBS) and have anxiolytic effects. Their therapeutic effects are related, in part, to reducing amygdala engagement during expected visceral pain. A single nucleotide polymorphism in HTR3A, c.-42C>T;(C178T; rs1062613), is associated with altered reactivity of the amygdala...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
